Recently, a research team from the School of Traditional Chinese Medicine of Shenyang Pharmaceutical University published an article titled "Gut opportunistic pathogens contribute to high-altitude pulmonary edema by elevating lysophosphatidylcholines and inducing inflammation" in the journal Microbiology Spectrum. The study revealed the mechanism by which intestinal flora (such as Klebsiella and Escherichia coli) promote high-altitude pulmonary edema (HAPE) by elevating lysophosphatidylcholine (LPC) levels and inducing inflammation.

Recently, a research team from the School of Traditional Chinese Medicine of Capital Medical University published an article titled "Investigation of the material basis and mechanism of Qingfei Paidu granules in treating LPS-induced acute pneumonia using UPLC-Q-TOF-MS/MS, network pharmacology, molecular docking and experimental verification" in the renowned journal Journal of Pharmaceutical and Biomedical Analysis. The article describes the research on the mechanistic principles of Qingfei Paidu Granules (QFPDG), a traditional Chinese medicine for treating lung diseases, including drug purification, component analysis, and in vitro and in vivo experiments. Let's explore the advancements in this traditional formula.

Bufan Xu's research team from the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, recently published a research paper titled "A Sweet Almond Globulin Multifunctional Peptide: Identification, In Silico Screening, Restraint Mechanisms to Keap1 and ACE, and Antihypertensive and Ferrous Transport Efficiency" in the international academic journal Nutrients...

In the field of drug delivery, nanotechnology has always been regarded as a potential stock to improve drug efficacy and reduce side effects.However, traditional nano-drug delivery systems often have difficulty in achieving a balance between penetration rate and in vivo retention time.This problem limits the application of nanomedicine in the treatment of respiratory diseases such as acute lung injury.

It is well known that the effectiveness of current SARS-CoV-2 vaccines and therapeutic antibodies is limited by the emergence of viral variants and the limited spread of circulating antibodies to sites of respiratory viral infection.null

Cardiovascular and cerebrovascular disease is a general term for cardiovascular and cerebrovascular diseases, and refers to ischemic or hemorrhagic diseases of the heart, brain, and systemic tissues caused by hyperlipidemia, blood viscosity, atherosclerosis, hypertension, etc.